4.3 Article

Patient characteristics driving clinical utility in psychiatric pharmacogenetics: a reanalysis from the AB-GEN multicentric trial

期刊

JOURNAL OF NEURAL TRANSMISSION
卷 126, 期 1, 页码 95-99

出版社

SPRINGER WIEN
DOI: 10.1007/s00702-018-1879-z

关键词

Depression; Pharmacogenetics; Precision medicine; Antidepressant response; Randomized clinical trial; Baseline severity

向作者/读者索取更多资源

Clinical utility of commercial multi-gene pharmacogenetic tests in depression is starting to be studied with some promising results on efficacy and tolerability. Among the next steps is the definition of the patient profile that is most likely to benefit from testing. Here we present a reanalysis of data from the AB-GEN randomized clinical trial showing that clinical utility of pharmacogenetic testing can be markedly influenced by patient characteristics such as age, baseline severity and duration of current depressive episode.Trial registration ClinicalTrials.gov NCT02529462.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据